|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang X and Li T: Development of a 15-gene
signature for predicting prognosis in advanced colorectal cancer.
Bioengineered. 11:165–174. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Poturnajova M, Furielova T, Balintova S,
Schmidtova S, Kucerova L and Matuskova M: Molecular features and
gene expression signature of metastatic colorectal cancer (Review).
Oncol Rep. 45:102021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Siraj S, Masoodi T, Siraj AK, Azam S,
Qadri Z, Ahmed SO, AlBalawy WN, Al-Obaisi KA, Parvathareddy SK,
AlManea HM, et al: Clonal evolution and timing of metastatic
colorectal cancer. Cancers (Basel). 12:29382020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shen A, Chen Y, Liu L, Huang Y, Chen H, Qi
F, Lin J, Shen Z, Wu X, Wu M, et al: EBF1-mediated upregulation of
ribosome assembly factor PNO1 contributes to cancer progression by
negatively regulating the p53 signaling pathway. Cancer Res.
79:2257–2270. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kobayashi K, Ogata H, Morikawa M, Iijima
S, Harada N, Yoshida T, Brown WR, Inoue N, Hamada Y, Ishii H, et
al: Distribution and partial characterisation of IgG Fc binding
protein in various mucin producing cells and body fluids. Gut.
51:169–176. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Stamp LA, Braxton DR, Wu J, Akopian V,
Hasegawa K, Chandrasoma PT, Hawes SM, McLean C, Petrovic LM, Wang
K, et al: The GCTM-5 epitope associated with the mucin-like
glycoprotein FCGBP marks progenitor cells in tissues of endodermal
origin. Stem Cells. 30:1999–2009. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Harada N, Iijima S, Kobayashi K, Yoshida
T, Brown WR, Hibi T, Oshima A and Morikawa M: Human IgGFc binding
protein (FcgammaBP) in colonic epithelial cells exhibits mucin-like
structure. J Biol Chem. 272:15232–15241. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Selbach M and Mann M: Protein interaction
screening by quantitative immunoprecipitation combined with
knockdown (QUICK). Nat Methods. 3:981–983. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang A, Wu L, Lin J, Han L, Bian J, Wu Y,
Robson SC, Xue L, Ge Y, Sang X, et al: Whole-exome sequencing
reveals the origin and evolution of hepato-cholangiocarcinoma. Nat
Commun. 9:8942018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou C, Chen H, Han L, Xue F, Wang A and
Liang YJ: Screening of genes related to lung cancer caused by
smoking with RNA-Seq. Eur Rev Med Pharmacol Sci. 18:117–125.
2014.PubMed/NCBI
|
|
13
|
Xiong L, Wen Y, Miao X and Yang Z: NT5E
and FcGBP as key regulators of TGF-1-induced epithelial-mesenchymal
transition (EMT) are associated with tumor progression and survival
of patients with gallbladder cancer. Cell Tissue Res. 355:365–374.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gazi MH, He M, Cheville JC and Young CY:
Downregulation of IgG Fc binding protein (Fc gammaBP) in prostate
cancer. Cancer Biol Ther. 7:70–75. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
O'Donovan N, Fischer A, Abdo EM, Simon F,
Peter HJ, Gerber H, Buergi U and Marti U: Differential expression
of IgG Fc binding protein (FcgammaBP) in human normal thyroid
tissue, thyroid adenomas and thyroid carcinomas. J Endocrinol.
174:517–524. 2002. View Article : Google Scholar
|
|
16
|
Choi CH, Choi JJ, Park YA, Lee YY, Song
SY, Sung CO, Song T, Kim MK, Kim TJ, Lee JW, et al: Identification
of differentially expressed genes according to chemosensitivity in
advanced ovarian serous adenocarcinomas: Expression of GRIA2
predicts better survival. Br J Cancer. 107:91–99. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang Y, Liu Y, Liu H, Zhang Q, Song H,
Tang J, Fu J and Wang X: FcGBP was upregulated by HPV infection and
correlated to longer survival time of HNSCC patients. Oncotarget.
8:86503–86514. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Witzmann FA, Arnold RJ, Bai F, Hrncirova
P, Kimpel MW, Mechref YS, McBride WJ, Novotny MV, Pedrick NM,
Ringham HN, et al: A proteomic survey of rat cerebral cortical
synaptosomes. Proteomics. 5:2177–2201. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Grant SG: The synapse proteome and
phosphoproteome: a new paradigm for synapse biology. Biochem Soc
Trans. 34((Pt 1)): 59–63. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dong S, Huo H, Mao Y, Li X and Dong L: A
risk score model for the prediction of osteosarcoma metastasis.
FEBS Open Bio. 9:519–526. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim M, Lee S, Yang SK, Song K and Lee I:
Differential expression in histologically normal crypts of
ulcerative colitis suggests primary crypt disorder. Oncol Rep.
16:663–670. 2006.PubMed/NCBI
|
|
22
|
Risques RA, Lai LA, Himmetoglu C, Ebaee A,
Li L, Feng Z, Bronner MP, Al-Lahham B, Kowdley KV, Lindor KD, et
al: Ulcerative colitis-associated colorectal cancer arises in a
field of short telomeres, senescence, and inflammation. Cancer Res.
71:1669–1679. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee S, Bang S, Song K and Lee I:
Differential expression in normal-adenoma-carcinoma sequence
suggests complex molecular carcinogenesis in colon. Oncol Rep.
16:747–754. 2006.PubMed/NCBI
|
|
24
|
Zhu H, Wu TC, Chen WQ, Zhou LJ, Wu Y, Zeng
L and Pei HP: Screening for differentially expressed genes between
left- and right-sided colon carcinoma by microarray analysis. Oncol
Lett. 6:353–358. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang W, Shi J, Zhou Y, Liu T, Zhan F,
Zhang K and Liu N: Integrating proteomics and transcriptomics for
the identification of potential targets in early colorectal cancer.
Int J Oncol. 55:439–450. 2019.PubMed/NCBI
|
|
26
|
Zhang GL, Pan LL, Huang T and Wang JH: The
transcriptome difference between colorectal tumor and normal
tissues revealed by single-cell sequencing. J Cancer. 10:5883–5890.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ma R, Jing C, Zhang Y, Cao H, Liu S, Wang
Z, Chen D, Zhang J, Wu Y, Wu J, et al: The somatic mutation
landscape of Chinese Colorectal Cancer. J Cancer. 11:1038–1046.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Qi C, Hong L, Cheng Z and Yin Q:
Identification of metastasis-associated genes in colorectal cancer
using metaDE and survival analysis. Oncol Lett. 11:568–574. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bendas G and Borsig L: Cancer cell
adhesion and metastasis: selectins, integrins, and the inhibitory
potential of heparins. Int J Cell Biol. 2012:6767312012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Onstenk W, Sieuwerts AM, Mostert B,
Lalmahomed Z, Bolt-de Vries JB, van Galen A, Smid M, Kraan J, Van
M, de Weerd V, et al: Molecular characteristics of circulating
tumor cells resemble the liver metastasis more closely than the
primary tumor in metastatic colorectal cancer. Oncotarget.
7:59058–59069. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Znalesniak EB, Fu T, Salm F, Händel U and
Hoffmann W: Transcriptional responses in the murine spleen after
toxoplasma gondii infection: inflammasome and mucus-associated
genes. Int J Mol Sci. 18:12452017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pelaseyed T, Bergström JH, Gustafsson JK,
Ermund A, Birchenough GM, Schütte A, van der Post S, Svensson F,
Rodríguez-Piñeiro AM, Nyström EE, et al: The mucus and mucins of
the goblet cells and enterocytes provide the first defense line of
the gastrointestinal tract and interact with the immune system.
Immunol Rev. 260:8–20. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lei X, Lei Y, Li JK, Du WX, Li RG, Yang J,
Li J, Li F and Tan HB: Immune cells within the tumor
microenvironment: Biological functions and roles in cancer
immunotherapy. Cancer Lett. 470:126–133. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Picard E, Verschoor CP, Ma GW and Pawelec
G: Relationships between immune landscapes, genetic subtypes and
responses to immunotherapy in colorectal cancer. Front Immunol.
11:3692020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Woolston A, Khan K, Spain G, Barber LJ,
Griffiths B, Gonzalez-Exposito R, Hornsteiner L, Punta M, Patil Y,
Newey A, et al: Genomic and transcriptomic determinants of therapy
resistance and immune landscape evolution during anti-egfr
treatment in colorectal cancer. Cancer Cell. 36:35–50.e9. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen J, Zeng Z, Huang L, Luo S, Dong J,
Zhou FH, Zhou K, Wang L and Kang L: Photothermal therapy technology
of metastatic colorectal cancer. Am J Transl Res. 12:3089–3115.
2020.PubMed/NCBI
|
|
37
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: a web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45((W1)):
W98–W102. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Rhodes DR, Kalyana-Sundaram S, Mahavisno
V, Varambally R, Yu J, Briggs BB, Barrette TR, Anstet MJ,
Kincead-Beal C, Kulkarni P, et al: Oncomine 3.0: Genes, pathways,
and networks in a collection of 18,000 cancer gene expression
profiles. Neoplasia. 9:166–180. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kaiser S, Park YK, Franklin JL, Halberg
RB, Yu M, Jessen WJ, Freudenberg J, Chen X, Haigis K, Jegga AG, et
al: Transcriptional recapitulation and subversion of embryonic
colon development by mouse colon tumor models and human colon
cancer. Genome Biol. 8:R1312007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Skrzypczak M, Goryca K, Rubel T, Paziewska
A, Mikula M, Jarosz D, Pachlewski J, Oledzki J and Ostrowski J:
Modeling oncogenic signaling in colon tumors by multidirectional
analyses of microarray data directed for maximization of analytical
reliability. PLoS One. 5:e130912010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Notterman DA, Alon U, Sierk AJ and Levine
AJ: Transcriptional gene expression profiles of colorectal adenoma,
adenocarcinoma, and normal tissue examined by oligonucleotide
arrays. Cancer Res. 61:3124–3130. 2001.PubMed/NCBI
|
|
42
|
Hong Y, Downey T, Eu KW, Koh PK and Cheah
PY: A ‘metastasis-prone’ signature for early-stage mismatch-repair
proficient sporadic colorectal cancer patients and its implications
for possible therapeutics. Clin Exp Metastasis. 27:83–90. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gaedcke J, Grade M, Jung K, Camps J, Jo P,
Emons G, Gehoff A, Sax U, Schirmer M, Becker H, et al: Mutated KRAS
results in overexpression of DUSP4, a MAP-kinase phosphatase, and
SMYD3, a histone methyltransferase, in rectal carcinomas. Genes
Chromosomes Cancer. 49:1024–1034. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chatterjee A, Ahn A, Rodger EJ, Stockwell
PA and Eccles MR: A guide for designing and analyzing RNA-Seq data.
Methods Mol Biol. 1783:35–80. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li T, Fan J, Wang B, Traugh N, Chen Q, Liu
JS, Li B and Liu XS: TIMER: A Web Server for Comprehensive Analysis
of Tumor-Infiltrating Immune Cells. Cancer Res. 77:e108–e110. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Li B, Severson E, Pignon JC, Zhao H, Li T,
Novak J, Jiang P, Shen H, Aster JC, Rodig S, et al: Comprehensive
analyses of tumor immunity: Implications for cancer immunotherapy.
Genome Biol. 17:1742016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Aran D, Sirota M and Butte AJ: Systematic
pan-cancer analysis of tumour purity. Nat Commun. 6:89712015.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Siemers NO, Holloway JL, Chang H, Chasalow
SD, Ross-MacDonald PB, Voliva CF and Szustakowski JD: Genome-wide
association analysis identifies genetic correlates of immune
infiltrates in solid tumors. PLoS One. 12:e01797262017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Danaher P, Warren S, Dennis L, D'Amico L,
White A, Disis ML, Geller MA, Odunsi K, Beechem J and Fling SP:
Gene expression markers of tumor infiltrating leukocytes. J
Immunother Cancer. 5:182017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Sousa S and Määttä J: The role of
tumour-associated macrophages in bone metastasis. J Bone Oncol.
5:135–138. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Siskova A, Cervena K, Kral J, Hucl T,
Vodicka P and Vymetalkova V: Colorectal adenomas-genetics and
searching for new molecular screening biomarkers. Int J Mol Sci.
21:32602020. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Idos GE, Kwok J, Bonthala N, Kysh L,
Gruber SB and Qu C: The Prognostic implications of tumor
infiltrating lymphocytes in colorectal cancer: a systematic review
and meta-analysis. Sci Rep. 10:33602020. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Dalal N, Jalandra R, Sharma M, Prakash H,
Makharia GK, Solanki PR, Singh R and Kumar A: Omics technologies
for improved diagnosis and treatment of colorectal cancer:
Technical advancement and major perspectives. Biomed Pharmacother.
131:1106482020. View Article : Google Scholar : PubMed/NCBI
|
